Abiopharma

New Form FWP - JPMORGAN CHASE & CO <b>Filed:</b> 2026-04-16 <b>AccNo:</b> 0001193125-26-158194 <b>Size:</b> 34 KB

(30% Negative) MARSH & MCLENNAN COMPANIES, INC. (MRSH) Reports Q2 2026 Financial Results

Announcement of AGM Results

MANHATTAN BRIDGE CAPITAL, INC (LOAN) Files Form 10-Q

TIZIANA LIFE SCIENCES LTD (TLSA) Files Form 6-K

JOINT STOCK CO KASPI.KZ (KSPI) Files Form 6-K

CareCloud Reaffirms Guidance Following Capital Structure Simplification, Capping a Decade of Transformation

DuPont Schedules First Quarter 2026 Earnings Conference Call

MeiraGTx Announces Positive Three-year Data from the Phase 1 AQUAx Clinical Study of AAV-hAQP1 for the Treatment of Grade 2/3 Late Radiation-Induced Xerostomia

Cielo Closes Strategic Asset Acquisition and Announces Intention to Appoint Chief Operating Officer and Chief Development Officer

Bausch + Lomb Reports Nearly 725,000 Pounds of Contact Lens, Lens Care and Eye Care Materials Collected and Recycled Through ONE By ONE Recycling Program

OceanaGold Provides Notice of First Quarter 2026 Results, Conference Call, and 2026 Annual Meeting of the Shareholders USA - English APAC - English

Tiziana Life Sciences Announces Publication of Positive Data Demonstrating Intranasal Anti-CD3 Antibody Attenuates Long COVID Neuroinflammation and Improves Cognitive Function

Glaukos Announces the Release of its 2025 Sustainability Report

Redefining Enterprise Engagement at InnoEX Hong Kong: Aurora Mobiles EngageLab Unveils AI-First Solutions